Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). Several therapies for it exist,...

Multiple sclerosis (MS) is an autoimmune disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. Being a demyelinating...

Tumefactive multiple sclerosis is a condition in which the central nervous system of a person has multiple demyelinating lesions with atypical characteristics...

The signs and symptoms of multiple sclerosis (MS) encompass a wide range of neurological and physical manifestations, including vision problems, muscle...

diagnosing multiple sclerosis (MS) are based on the 2018 revision of McDonald criteria. They rely on MRI detection (or clinical demonstration) of demyelinating...

Malignant multiple sclerosis is used to describe MS patients who reach significant level of disability in a short period of time. Malignant MS cases are...

There are several ways for pharmaceuticals for treating multiple sclerosis (MS) to reach the market. Novel pharmaceuticals cannot enter the US market without...

The National Multiple Sclerosis Society (NMSS) is an American nonprofit organization founded in 1946. It is an organization dedicated to supporting individuals...

effectiveness of TENS in relation to pain management of multiple sclerosis (MS). MS is a chronic autoimmune neurological disorder, which consists of the demyelination...

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND) or Lou Gehrig's disease in the United States, is a rare, terminal neurodegenerative...

(1909–2008), academic neurologist at the University of Oregon, for the treatment of multiple sclerosis. The claims made for the diet are unsubstantiated...

The Multiple Sclerosis Trust (MS Trust) is an independent, national UK charity that was established in 1993. The MS Trust works to provide information...

from Multiple Sclerosis, but considered by others to form a spectrum differing only in terms of chronicity, severity, and clinical course. Multiple sclerosis...

investigational RIPK1 inhibitor that may be useful in the management of multiple sclerosis. An autoinflammatory disease characterised by recurrent fevers...

occasionally used in the management of multiple sclerosis (MS), because anecdotal reports indicated a positive effect (reversal of symptoms) of a GFD in MS patients...

Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant genetic disease that causes non-cancerous tumours to grow in the brain and on...

treatment for relapsing-remitting multiple sclerosis (RRMS) under the brand name Nerventra. Management of multiple sclerosis Tan IL, Lycklama à Nijeholt GJ...

optica (NMO), Balo concentric sclerosis and Marburg multiple sclerosis. Symptoms are similar to those in multiple sclerosis and may include dementia, aphasia...

Uhthoff's sign, and Uhthoff's symptom) is the worsening of neurologic symptoms in multiple sclerosis (MS) and other demyelinating diseases when the body is...

consists of a mixture of histamine and caffeine. It is marketed as a treatment for fatigue in multiple sclerosis (MS), although in the 1950s multiple sclerosis...

disorder (ADHD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). It has been reported as a symptom of hyperthyroidism...

autoimmunity, and when it appears in multiple sclerosis (MS) cases, it's misdiagnosed as multiple sclerosis (MS) or seen as a type of MS. But NMO is a different...

multiple sclerosis, and sleep apnea learn to understand their condition and live successfully with it. This term is equivalent to disease management for...

the research stage. The Tuberous Sclerosis Alliance has published guidelines on diagnosis, surveillance, and management. Most people with benign angiomyolipomas...

beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells, while interferon beta-1b...

symptoms of multiple sclerosis; it was developed by the UK company GW Pharmaceuticals. In 2019, it was proposed that following application of the spray...

(NIHR). His main area of expertise is in the diagnosis, evaluation, and management of progressive forms of multiple sclerosis.  His work focuses on the...

the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease. It is a humanized monoclonal antibody against...

Oligoclonal bands are present in the CSF of more than 95% of patients with clinically definite multiple sclerosis. Two methods of analysis are possible: (a) protein...

Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. Fingolimod is a sphingosine-1-phosphate receptor modulator, which...